CurrentEndo coverage · page 26 of 33

Cardiovascular Diabetology

Briefs 1,001–1,040 of 1,291 CurrentEndo has covered from this journal, newest publication first

Latest from Cardiovascular Diabetology

All coverage, newest first

Cardiovasc Diabetol20 Dec 2023
Combined effect of adiposity and elevated inflammation on incident type 2 diabetes: a prospective cohort study
Cohort studyT2D & other
Cardiovasc Diabetol20 Dec 2023
Primary aldosteronism and lower-extremity arterial disease: a two-sample Mendelian randomization study
Diagnostic or prognostic studyAdrenal
Cardiovasc Diabetol19 Dec 2023
Prediabetes increases the risk of major limb and cardiovascular events
Cohort studyT2D & other
Cardiovasc Diabetol19 Dec 2023
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes
Randomized controlled trialT2D & other
Cardiovasc Diabetol19 Dec 2023
Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosis
Cross-sectional study
Cardiovasc Diabetol15 Dec 2023
The triglyceride glucose index trajectory is associated with hypertension: a retrospective longitudinal cohort study
Cohort study
Cardiovasc Diabetol13 Dec 2023
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease
Cross-sectional studyComplications
Cardiovasc Diabetol13 Dec 2023
Obesity indices and the risk of total and cardiovascular mortality among people with diabetes: a long-term follow-up study in Taiwan
Cohort studyT2D & other
Cardiovasc Diabetol13 Dec 2023
Triglyceride-glucose index is associated with a higher risk of stroke in a hypertensive population
Cohort studyLipids & liver
Cardiovasc Diabetol13 Dec 2023
Olive oil consumption, plasma metabolites, and risk of type 2 diabetes and cardiovascular disease
Randomized controlled trialT2D & other
Cardiovasc Diabetol13 Dec 2023
Association of metabolic dysfunction-associated fatty liver disease with systemic atherosclerosis: a community-based cross-sectional study
Cross-sectional studyLipids & liver
Cardiovasc Diabetol13 Dec 2023
Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study
Cohort studyLipids & liver
Cardiovasc Diabetol13 Dec 2023
Multi-trajectories of triglyceride-glucose index and lifestyle with Cardiovascular Disease: a cohort study
Cohort study
Cardiovasc Diabetol13 Dec 2023
Magnitude and time course of insulin resistance accumulation with the risk of cardiovascular disease: an 11-years cohort study
Cohort studyLipids & liver
Cardiovasc Diabetol12 Dec 2023
Opposite causal effects of birthweight on myocardial infarction and atrial fibrillation and the distinct mediating pathways: a Mendelian randomization study
Research articleObesity
Cardiovasc Diabetol8 Dec 2023
Effects of diabetes mellitus and glycemic traits on cardiovascular morpho-functional phenotypes
Research articleT2D & other
Cardiovasc Diabetol8 Dec 2023
Effects of exenatide on coronary stent’s endothelialization in subjects with type 2 diabetes: a randomized controlled trial. The Rebuild study
Randomized controlled trialT2D & other
Cardiovasc Diabetol8 Dec 2023
Isthmin-1 (ISM1), a novel adipokine that reflects abdominal adipose tissue distribution in individuals with obesity
Research articleObesity
Cardiovasc Diabetol6 Dec 2023
Impact of stress hyperglycemia ratio, derived from glycated albumin or hemoglobin A1c, on mortality among ST-segment elevation myocardial infarction patients
Cohort studyComplications
Cardiovasc Diabetol6 Dec 2023
An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel disease
Cohort studyT2D & other
Cardiovasc Diabetol28 Nov 2023
Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands
Cohort studyT2D & other
Cardiovasc Diabetol28 Nov 2023
Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial
Secondary analysisT2D & other
Cardiovasc Diabetol28 Nov 2023
Temporal relationship between triglyceride-glucose index and blood pressure and their joint cumulative effect on cardiovascular disease risk: a longitudinal cohort study
Cohort studyLipids & liver
Cardiovasc Diabetol28 Nov 2023
Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study
Cross-sectional studyT2D & other
Cardiovasc Diabetol28 Nov 2023
Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials
Meta-analysisLipids & liver
Cardiovasc Diabetol28 Nov 2023
Association of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004–2015 cohort studies: no obesity paradox?
Cohort studyObesity
Cardiovasc Diabetol28 Nov 2023
Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention
Cohort studyLipids & liver
Cardiovasc Diabetol28 Nov 2023
Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study
Cohort studyLipids & liver
Cardiovasc Diabetol22 Nov 2023
Association between the triglyceride–glucose index and left ventricular global longitudinal strain in patients with coronary heart disease in Jilin Province, China: a cross-sectional study
Cross-sectional studyLipids & liver
Cardiovasc Diabetol22 Nov 2023
Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population
Cohort studyLipids & liver
Cardiovasc Diabetol20 Nov 2023
Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors: cardiovascular effects in people with diabetes and cardiovascular disease
Cohort studyT2D & other
Cardiovasc Diabetol20 Nov 2023
Machine learning identification of risk factors for heart failure in patients with diabetes mellitus with metabolic dysfunction associated steatotic liver disease (MASLD): the Silesia Diabetes-Heart Project
Diagnostic or prognostic studyT2D & other
Cardiovasc Diabetol20 Nov 2023
Effects of diabetes mellitus on left ventricular function and deformation in patients with restrictive cardiomyopathies: a 3.0T CMR feature tracking study
Cross-sectional studyT2D & other
Cardiovasc Diabetol16 Nov 2023
Association of glycemic variability with death and severe consciousness disturbance among critically ill patients with cerebrovascular disease: analysis of the MIMIC-IV database
Cohort studyComplications
Cardiovasc Diabetol15 Nov 2023
Relationship between the cumulative exposure to atherogenic index of plasma and ischemic stroke: a retrospective cohort study
Cohort study
Cardiovasc Diabetol13 Nov 2023
Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy
Mechanistic studyComplications
Cardiovasc Diabetol9 Nov 2023
Association between insulin resistance and uncontrolled hypertension and arterial stiffness among US adults: a population-based study
Cross-sectional studyLipids & liver
Cardiovasc Diabetol8 Nov 2023
Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes
Cross-sectional studyT2D & other
Cardiovasc Diabetol8 Nov 2023
Triglyceride-glucose index in the prediction of clinical outcomes after successful recanalization for coronary chronic total occlusions
Cohort study
Cardiovasc Diabetol8 Nov 2023
Triglycerides/HDL cholesterol ratio and type 2 diabetes incidence: Panasonic Cohort Study 10
Cohort studyT2D & other

All 1,291 Briefs in ExploreShowing Briefs 1,001–1,040 of 1,291, newest first